An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Instituto de Investigaciones Biomédicas, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, Mexico. Electronic address: citlalli.osorio@iibiomedicas.unam.mx.; Department of Developmental Neurobiology, National Institute of Perinatology, Mexico City, Mexico. Electronic address: msanchezguerra@alumni.harvard.edu.; Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Brigham and women's Hospital, Boston, MA, USA.; Department of Biostatistics, School of Public Health and Human Sciences, University of Massachusetts Amherst, Amherst, MA, USA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.; Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME, USA; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Department of Environmental Health, Boston University School of Public Health, Boston, MA, USA.; Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Authors
Osorio-Yáñez Citlalli, Sanchez-Guerra Marco, Cardenas Andres, Lin Pi-I D, Hauser Russ, Gold Diane R, Kleinman Ken P, Hivert Marie-France, Fleisch Abby F, Calafat Antonia M, Webster Thomas F, Horton Edward S, Oken Emily
Studies
Abstract
Per- and polyfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that have been associated with cardiovascular risk factors including elevated body weight and hypercholesterolemia. Therefore, PFAS may contribute to the development of atherosclerosis and cardiovascular disease (CVD). However, no previous study has evaluated associations between PFAS exposure and arterial calcification.